Chemotherapy Regimens in Metastatic Breast Cancer

Stefan Glück, MD, PhD, FRCPC Sylvester Professor, Department of Medicine Assistant Director, Sylvester Comprehensive Cancer Center Associate Chief, Division of Hematology/Oncology University of Miami, Leonard M. […]

Importance of Accurate HER2 Testing in Patients With Metastatic Breast Cancer

Ana Maria Gonzalez-Angulo, MD, MSc, FACP Associate Professor Department of Breast Medical Oncology Department of Systems Biology Division of Cancer Medicine The University of Texas MD […]

Adjuvant Therapy for Stage II and III Colon Cancer

Jeffrey A. Meyerhardt, MD, MPH Assistant Professor of Medicine Harvard Medical School Dana-Farber Cancer Institute Boston, Massachusetts H&O How is stage II colon cancer different from stage […]

PARP Inhibition Outside of BRCA Mutation Carriers

Steven J. Isakoff, MD, PhD Instructor, Department of Medicine Harvard Medical School Massachusetts General Hospital Cancer Center Boston, Massachusetts H&O What is triple negative breast cancer? SI Triple […]

Update on Treatment Options for Newly Diagnosed Ovarian Cancer

Deborah Armstrong, MD Associate Professor of Oncology Department of Gynecology and Obstetrics Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland H&O What are some of the […]

Effects of Vitamin D in Colorectal Cancer

Kimmie Ng, MD, MPH Gastrointestinal Cancer Center Dana-Farber Cancer Institute Boston, Massachusetts H&O What is the relationship between vitamin D and colorectal cancer? KN There is a long […]

Current Status of Axillary Lymph Node Dissection and Sentinel Node Biopsy in Breast Cancer

David N. Krag, MD S.D. Ireland Professor of Surgical Oncology University of Vermont College of Medicine Burlington, Vermont H&O What has been the routine use of axillary […]

Immunotherapeutic Approaches in Prostate Cancer: PROVENGE

Nancy Dawson, MD Director of Clinical Research Lombardi Comprehensive Cancer Center Georgetown University Washington, DC H&O What is the current state of therapy for patients with advanced […]

Treatment Considerations in Elderly Colorectal Cancer Patients

Colorectal Cancer In Focus Nadine Jackson McCleary, MD, MPH Instructor in Medicine, Harvard Medical School Dana-Farber Cancer Institute Boston, Massachusetts H&O What are the treatment considerations in […]

Update on Administration of Adjuvant Trastuzumab

Heather L. McArthur, MD, MPH Assistant Attending Breast Cancer Medicine Service Memorial Sloan-Kettering Cancer Center New York, New York H&O What factors are considered when deciding whether […]

Denosumab Findings in Metastatic Breast Cancer

Breast Cancer In Focus Denosumab Findings in Metastatic Breast Cancer Alison Stopeck, MD, Associate Professor of Medicine, University of Arizona Cancer Center, Tucson, Arizona H&O What is the current approach […]

Melphalan for Colorectal Metastases to the Liver

Colorectal Cancer In Focus Melphalan for Colorectal Metastases to the Liver James F. Pingpank, MD, FACS , Associate Professor of Surgery , Division of Surgical Oncology University of […]

Updates on Therapeutic Approaches in HER2-positive Disease

Updates on Therapeutic Approaches in HER2-positive Disease Maura N. Dickler, MD, Medical Oncologist, Memorial Sloan-Kettering Cancer Center New York, New York H&O What are the characteristics of HER2-positive breast cancer? MD […]

Panitumumab and Combination Chemotherapy in First- and Second-line Therapy for Colorectal Cancer

Panitumumab and Combination Chemotherapy in First- and Second-line Therapy for Colorectal Cancer Emily Chan, MD, PhD, Assistant Professor of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee H&O What do we know of the […]

Role of Local Liver Therapy for Hepatic Metastases from Colorectal Cancer

Role of Local Liver Therapy for Hepatic Metastases from Colorectal Cancer Nancy Kemeny, MD, Professor of Medicine, Weill Medical College of Cornell University, Medical Oncologist, Memorial […]

HER2 Vaccination in High-risk Breast Cancer

George E. Peoples, MD, FACS Director, Cancer Vaccine Development Program, Deputy Director, U.S. Military Cancer Institute , Chief, Surgical Oncology, Department of Surgery, Brooke Army Medical Center, Fort Sam Houston, […]